These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

820 related items for PubMed ID: 17444031

  • 21. Bolstering the FDA's drug-safety authority.
    Schultz WB.
    N Engl J Med; 2007 Nov 29; 357(22):2217-9. PubMed ID: 18046024
    [No Abstract] [Full Text] [Related]

  • 22. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK.
    Food Drug Law J; 2006 Nov 29; 61(2):385-418. PubMed ID: 16903035
    [No Abstract] [Full Text] [Related]

  • 23. Marketing off-label uses to physicians: FDA's draft (mis)guidance.
    Gass A, Wilson J.
    Am J Bioeth; 2008 Mar 29; 8(3):1-3. PubMed ID: 18570084
    [No Abstract] [Full Text] [Related]

  • 24. Pharmaceuticals and medical devices: FDA oversight.
    Health Policy Tracking Service, a service of Thomson Reuters Accelus, Berry MD.
    Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-86. PubMed ID: 22403845
    [No Abstract] [Full Text] [Related]

  • 25. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC.
    Cornell Law Rev; 2008 Jul 03; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract] [Full Text] [Related]

  • 26. FDA preemption of drug and device labeling: who should decide what goes on a drug label?
    Valoir T, Ghosh S.
    Health Matrix Clevel; 2011 Jul 03; 21(2):555-98. PubMed ID: 22145525
    [Abstract] [Full Text] [Related]

  • 27. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan 03; 12(1):6. PubMed ID: 8428434
    [No Abstract] [Full Text] [Related]

  • 28. Why doctors should worry about preemption.
    Curfman GD, Morrissey S, Drazen JM.
    N Engl J Med; 2008 Jul 03; 359(1):1-3. PubMed ID: 18596269
    [No Abstract] [Full Text] [Related]

  • 29. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ.
    Healthspan; 1991 Nov 03; 8(10):3-7. PubMed ID: 10114942
    [No Abstract] [Full Text] [Related]

  • 30. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
    Surprenant JA.
    Fordham Law Rev; 2008 Oct 03; 77(1):327-63. PubMed ID: 18982554
    [Abstract] [Full Text] [Related]

  • 31. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
    Kraushaar KJ.
    Food Drug Law J; 1999 Oct 03; 54(2):243-4. PubMed ID: 11758581
    [No Abstract] [Full Text] [Related]

  • 32. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM.
    Food Drug Law J; 1996 Oct 03; 51(4):631-5. PubMed ID: 11797732
    [No Abstract] [Full Text] [Related]

  • 33. Higher First Amendment hurdles for public health regulation.
    Outterson K.
    N Engl J Med; 2011 Aug 18; 365(7):e13. PubMed ID: 21812665
    [No Abstract] [Full Text] [Related]

  • 34. Pharmaceutical promotion and First Amendment rights.
    Troy DE, Gottlieb S.
    N Engl J Med; 2008 Jul 31; 359(5):536; author reply 536-7. PubMed ID: 18669437
    [No Abstract] [Full Text] [Related]

  • 35. Access to safety data--stockholders versus prescribers.
    Pfeffer MA, Bowler MB.
    N Engl J Med; 2011 Jul 07; 365(1):1-3. PubMed ID: 21714642
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
    Boumil MM, Curfman G.
    JAMA; 2018 Aug 14; 320(6):547-548. PubMed ID: 30039167
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.